Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Learn which fund family offers the best Sharpe ratio indices and why it matters for risk-adjusted performance. Compare funds to identify strong performers.
28,055 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
A major insider purchase by BORR's Executive Director has investors buzzing. This article breaks down what the move c...
A new open-source coalition backed by Mozilla is mobilizing policymakers and investors to curb Big Tech’s control ove...
Ripple secures full authorization under MiCA from Luxembourg's CSSF, enabling its XRP-based payments platform to oper...
Goldman Sachs warns that China's oil demand may not return to its pre-crisis trajectory, highlighting a potential, la...
A cross-chain protocol says purchased tokens on Robinhood Chain vanished from users’ wallets, with losses tied to sus...
Netflix is tightening access to viewing data as it trims public reporting on audience insights, prompting a cautious ...
SpaceX’s IPO buzz is reshaping how traders view tech hardware plays. This story explains why micron stock after space...
Micron Technology faces a pivotal June 24 earnings moment as AI-driven memory demand tests its growth outlook. A stro...
Strobe Finance, the XRP Ledger EVM Sidechain’s sole native lending protocol, is winding down. Users must repay loans ...
SoFi stock is showing signs of a renewed uptrend as growth catalysts and insider activity bolster a case for double-d...
When a company’s chairman unloads a sizable stake, investors naturally want to know why. This article breaks down a r...